UFF
ELV icon

USA Financial Formulas’s Elevance Health ELV Stock Holding History

USA Financial Formulas’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,093
Closed -$1.09M – 313
2024
Q3 		$1.09M Sell
2,093
-470
-18% -$251K 0.17% 59
2024
Q2 		$1.39M Buy
2,563
+2,336
+1,029% +$1.23M 0.23% 30
2024
Q1 		$118K Buy
227
+23
+11% +$11.4K 0.02% 192
2023
Q4 		$96.2K Buy
204
+195
+2,167% +$90.2K 0.02% 172
2023
Q3 		$3.92K Hold
9
– – 0.01% 266
2023
Q2 		$4K Hold
9
– – 0.01% 232
2023
Q1 		$4.14K Buy
+9
New +$4.28K 0.01% 178
2022
Q3 		$10K Sell
21
-2,099
-99% -$1M 0.02% 113
2022
Q2 		$1.02M Buy
2,120
+1,933
+1,034% +$956K 1.28% 21
2022
Q1 		$92K Sell
187
-47
-20% -$21.5K 0.1% 99
2021
Q4 		$108K Buy
234
+196
+516% +$82.5K 0.09% 113
2021
Q3 		$14K Buy
38
+23
+153% +$8.74K 0.01% 234
2021
Q2 		$6K Sell
15
-23
-61% -$8.79K 0.01% 252
2021
Q1 		$14K Buy
38
+13
+52% +$4.18K 0.01% 208
2020
Q4 		$8K Sell
25
-2
-7% -$614 0.01% 187
2020
Q3 		$7K Buy
27
+21
+350% +$5.65K 0.01% 163
2020
Q2 		$2K Sell
6
-13
-68% -$3.47K ﹤0.01% 119
2020
Q1 		$4K Buy
19
+3
+19% +$818 ﹤0.01% 161
2019
Q4 		$5K Buy
+16
New +$4.4K ﹤0.01% 178
2019
Q3 		– Sell
-5,847
Closed -$1.68M – 224
2019
Q2 		$1.68M Buy
5,847
+1,370
+31% +$374K 0.84% 42
2019
Q1 		$1.28M Buy
+4,477
New +$1.29M 0.81% 42
2017
Q4 		– Sell
-18,541
Closed -$3.52M – 283
2017
Q3 		$3.52M Sell
18,541
-1,254
-6% -$239K 0.84% 40
2017
Q2 		$3.72M Buy
+19,795
New +$3.56M 0.9% 34
2015
Q3 		– Sell
-15,867
Closed -$2.6M – 125
2015
Q2 		$2.6M Sell
15,867
-747
-4% -$119K 0.8% 32
2015
Q1 		$2.56M Buy
16,614
+1,108
+7% +$158K 0.84% 33
2014
Q4 		$1.95M Buy
+15,506
New +$1.92M 0.67% 61

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

USA Financial Formulas's ELV Position: Q4 2024 in Review

USA Financial Formulas sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 2,093 shares — an estimated $1.09M sold.

USA Financial Formulas first reported a position in ELV in Q4 2014 and held it in 26 quarters. The position peaked at $3.72M in Q2 2017. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • USA Financial Formulas reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • USA Financial Formulas sold 2,093 Elevance Health shares in Q4 2024, an estimated $1.09M.
  • USA Financial Formulas first reported a position in Elevance Health in Q4 2014 and held it in 26 quarters.
  • USA Financial Formulas's Elevance Health position peaked at $3.72M in Q2 2017.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on USA Financial Formulas's 13F filing for Q4 2024, filed 14 Jan 2025.